Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial

Abstract

Objective: The impact of faecal microbiota transplantation (FMT) on microbiota engraftment in patients with metabolic syndrome is uncertain. We aimed to study whether combining FMT with lifestyle modification could enhance the engraftment of favourable microbiota in obese patients with type 2 diabetes mellitus (T2DM). Design: In this double-blind, randomised, placebo-controlled trial, 61 obese subjects with T2DM were randomly assigned to three parallel groups: FMT plus lifestyle intervention (LSI), FMT alone, or sham transplantation plus LSI every 4 weeks for up to week 12. FMT solution was prepared from six healthy lean donors. Faecal metagenomic sequencing was performed at baseline, weeks 4, 16 and 24. The primary outcome was the proportion of subjects acquiring ≥20% of microbiota from lean donors at week 24. Results: Proportions of subjects acquiring ≥20% of lean-associated microbiota at week 24 were 100%, 88.2% and 22% in the FMT plus LSI, FMT alone, and sham plus LSI groups, respectively (p<0.0001). Repeated FMTs significantly increased the engraftment of lean-associated microbiota (p<0.05). FMT with or without LSI increased butyrate-producing bacteria. Combining LSI and FMT led to increase in Bifidobacterium and Lactobacillus compared with FMT alone (p<0.05). FMT plus LSI group had reduced total and low-density lipoprotein cholesterol and liver stiffness at week 24 compared with baseline (p<0.05). Conclusion: Repeated FMTs enhance the level and duration of microbiota engraftment in obese patients with T2DM. Combining lifestyle intervention with FMT led to more favourable changes in recipients’ microbiota and improvement in lipid profile and liver stiffness. Trial registration number: NCT03127696 .

Overview

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2020-323617

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 32 references

Cited by

See all 262

Metadata

Authors
Ng, S. C., Xu, Z., Mak, J. W. Y., Yang, K., Liu, Q., Zuo, T., Tang, W., Lau, L., Lui, R. N., Wong, S. H., Tse, Y. K., Li, A. Y. L., Cheung, K., Ching, J. Y. L., Wong, V. W. S., Kong, A. P. S., Ma, R. C. W., Chow, E. Y. K., Wong, S. K. H., Ho, I. C. H., Chan, P. K. S., & Chan, F. K. L.
Affiliations
Chinese University of Hong Kong (HK)
Corresponding author
Chan, Francis K L
Venue
Gut
Publisher
BMJ
Published
2021-03-30
Volume
71
Issue
4
Pages
716-723
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W3144513022
Cited by
249
References
32
Citations by year
2026: 46 · 2025: 63 · 2024: 54 · 2023: 44 · 2022: 36 · 2021: 5
FWCI
10.90
Type
journal article
Language
en
Open access
closed
Locations
  • Gut (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • InnoHK, The Government of Hong Kong, Special Administrative Region of the People’s Republic of China (NA)
  • Chinese University of Hong Kong (seed fund from Center for Gut Microbiota Research)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
fecal microbiota transplantation, type 2 diabetes, obesity, lifestyle intervention, butyrate-producing bacteria, Bifidobacterium, Lactobacillus, lipid profile, liver stiffness, metabolic syndrome
MeSH terms
Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Diabetes Mellitus, Type 2, Double-Blind Method, Feces, Humans, Obesity, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial. https://app.cochat.ai/papers/10.1136/gutjnl-2020-323617
The paper
Ng, S. C., Xu, Z., Mak, J. W. Y., Yang, K., Liu, Q., Zuo, T., Tang, W., Lau, L., Lui, R. N., Wong, S. H., Tse, Y. K., Li, A. Y. L., Cheung, K., Ching, J. Y. L., Wong, V. W. S., Kong, A. P. S., Ma, R. C. W., Chow, E. Y. K., Wong, S. K. H., . . . Chan, F. K. L. (2022). Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial. Gut. https://doi.org/10.1136/gutjnl-2020-323617

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.